SCHEMBL23649366

SCHEMBL23649366

Nc1nc(-c2ccccc2)cnc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.49
ATR Q13535 3/20 0.47
PRKDC P78527 1/20 0.45
ADORA2A P29274 3/20 0.44
ADORA1 P30542 3/20 0.44
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
AURKA O14965 1/20 0.44
HSP90AA1 P07900 1/20 0.44
PRKACA P17612 1/20 0.44
NPC1 O15118 1/20 0.43
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NOS1 P29475 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31638393 0.85 ATR (0.51) TLR9ATRPRKDCADORA2AADORA1
SCHEMBL934804 0.85 ATR (0.51) TLR9ATRPRKDCADORA2AADORA1
SCHEMBL12489014 0.82 ATR (0.56) TLR9ATRPRKDCADORA2AADORA1
SCHEMBL29519952 0.82 ATR (0.56) TLR9ATRPRKDCADORA2AADORA1
SCHEMBL32688927 0.74 ATR (0.66) TLR9ATRPRKDC
SCHEMBL6701248 0.74 ATR (0.66) TLR9ATRPRKDC
SCHEMBL25351761 0.74 FGFR1 (0.40) ATRPRKDCMAPK1KDM4EMAPT
SCHEMBL3524358 0.73 BCHE (0.44) TLR9MAPK1MAPTL3MBTL1NPC1
SCHEMBL16629029 0.73 ATR (0.51) TLR9ATRPRKDCADORA2AADORA1
SCHEMBL2681285 0.73 SMN1; SMN2 (0.51) TLR9ATRPRKDCADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021146629-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2021-07-22 WO disclosed
WO-2021146629-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2021-07-22 WO disclosed